QIANHAI HEALTH Reports 40.43% Drop in Interim Net Profit

Stock News

08/12

QIANHAI HEALTH (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.

Revenue for the period totaled HK$117 million, down 65.74% year-on-year. Earnings per share stood at 1.68 HK cents.

The company stated that over 98% of its total revenue during the interim period continued to come from its electronic components business. The decline in revenue and gross profit was primarily attributed to supply constraints, upstream quota restrictions, extended channel delivery times, and lower trading volumes.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1143735034"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143735034\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143735034?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 16:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143735034","market":"us","top_or_hot":-1,"title":"QIANHAI HEALTH Reports 40.43% Drop in Interim Net Profit","media":"Stock News","content":"<p><b>QIANHAI HEALTH</b> (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.<br><br>Revenue for the period totaled HK$117 million, down 65.74% year-on-year. Earnings per share stood at 1.68 HK cents.<br><br>The company stated that over 98% of its total revenue during the interim period continued to come from its electronic components business. The decline in revenue and gross profit was primarily attributed to supply constraints, upstream quota restrictions, extended channel delivery times, and lower trading volumes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QIANHAI HEALTH Reports 40.43% Drop in Interim Net Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQIANHAI HEALTH Reports 40.43% Drop in Interim Net Profit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-08-12 16:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>QIANHAI HEALTH</b> (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.<br><br>Revenue for the period totaled HK$117 million, down 65.74% year-on-year. Earnings per share stood at 1.68 HK cents.<br><br>The company stated that over 98% of its total revenue during the interim period continued to come from its electronic components business. The decline in revenue and gross profit was primarily attributed to supply constraints, upstream quota restrictions, extended channel delivery times, and lower trading volumes.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1162","symbol_name":"技術產品經銷商","start_time":0,"source_url":"","article_id":"1143735034","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143735034","pubTimestamp":1786523785,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"QIANHAI HEALTH (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.Revenue for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1162":"技术产品经销商","BK1181":"经销商","00911":"前海健康"},"translate_title":"前海健康报告中期净利润下降40.43%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00911":1},"content_text":"QIANHAI HEALTH (00911) has released its interim results for the 2026 financial year, reporting a net profit of HK$2.844 million, a decrease of 40.43% compared to the same period last year.Revenue for the period totaled HK$117 million, down 65.74% year-on-year. Earnings per share stood at 1.68 HK cents.The company stated that over 98% of its total revenue during the interim period continued to come from its electronic components business. The decline in revenue and gross profit was primarily attributed to supply constraints, upstream quota restrictions, extended channel delivery times, and lower trading volumes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}